![Brandon Hants](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brandon Hants
No más puestos en curso
Fortuna: 570 $ al 30/11/2023
Perfil
Brandon Hants served as the Chief Financial Officer at Singulex, Inc. from 2018 to 2019, and at Applied Molecular Transport, Inc. from 2022 to 2023.
He received an undergraduate degree from the University of California, Santa Barbara, and an MBA from the University of San Francisco.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
27/12/2023 | 2 921 ( 0.01% ) | 570 $ | 30/11/2023 |
Antiguos cargos conocidos de Brandon Hants.
Empresas | Cargo | Fin |
---|---|---|
APPLIED MOLECULAR TRANSPORT INC. | Director Financiero/CFO | 27/12/2023 |
Singulex, Inc.
![]() Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Director Financiero/CFO | 01/01/2019 |
Formación de Brandon Hants.
University of San Francisco | Masters Business Admin |
University of California, Santa Barbara | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Singulex, Inc.
![]() Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Brandon Hants